Jasper Therapeutics (JSPR)
(Delayed Data from NSDQ)
$18.10 USD
+0.12 (0.67%)
Updated Aug 15, 2024 04:00 PM ET
After-Market: $18.28 +0.18 (0.99%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Brokerage Reports
0 items in cart
Jasper Therapeutics, Inc. [JSPR]
Reports for Purchase
Showing records 1 - 3 ( 3 total )
Company: Jasper Therapeutics, Inc.
Industry: Unclassified
Mast Cell Depletion Could Be a Differentiating MoA for Treatment of Asthma
Provider: H.C. Wainwright & Co., Inc.
Analyst: BODNAR E
Company: Jasper Therapeutics, Inc.
Industry: Unclassified
1Q24 Recap: Phase 1/2 CSU and CIndU Data Readouts on Track for 2H24
Provider: H.C. Wainwright & Co., Inc.
Analyst: BODNAR E
Company: Jasper Therapeutics, Inc.
Industry: Unclassified
|